In September, Dr. Jinjiang Guo, Head of Data Science at the Global Health Drug Discovery Institute (GHDDI), participated in the 16th Pujiang Innovation Forum - Global Health and Development Summit as a panelist. He shared his insights on current challenges and the role of new technologies in advancing global health. Looking ahead, Dr. Guo envisions the development of AI models that seamlessly integrate dynamic, multimodal, multilevel, and multiscale high-quality data. Such models would enable a deep understanding of disease progression mechanisms and provide valuable insights to scientists, enhancing the efficiency of drug discovery efforts. GHDDI leverages technologies such as AI, physics simulation, and bioinformatics analysis to identify pathogenic targets, and identify and optimize effective compounds. This accelerates the drug development process and reduces R&D costs. We are committed to improving global health through the accelerated development of new drugs and innovative technologies! Learn more about us: ghddi.org/en #AI #drugdiscovery #globalhealth #GreatScienceForGlobalHealth
